Weisi Ning (韦司宁)韦司宁
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 北京四环科宝制药有限公司Chinese legal name: 北京四环科宝制药有限公司
主要成分Active Ingredients
- 主要含多肽Zhuyao Handuo Tai
- 氨基酸Anji Suan
- 核苷He Gan
- 核苷酸等Hegan Suandeng
药物知识说明
主要含多肽是一种在国家药监局注册认定的药品。该药品含有主要含多肽、核苷、核苷酸等-864ddda9等成分。
该药品关联的活性成分包括：主要含多肽Zhuyao Handuo Tai、核苷He Gan、核苷酸等Hegan Suandeng、氨基酸Anji Suan。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：北京四环科宝制药有限公司Chinese legal name: 北京四环科宝制药有限公司。
您可以探索含有相同成分的其他药品：主要含多肽-b6915e42成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 韦司宁) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 主要含多肽Zhuyao Handuo Tai, 核苷He Gan, 核苷酸等Hegan Suandeng, 氨基酸Anji Suan.
Manufacturers recorded for this product: 北京四环科宝制药有限公司Chinese legal name: 北京四环科宝制药有限公司.
Explore other medicines containing the same ingredient: 主要含多肽 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 韦司宁Recorded Chinese name: 韦司宁
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 多肽3.5mg与次黄嘌呤0.5mg。Recorded Chinese description: 多肽3.5mg与次黄嘌呤0.5mg。
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 北京四环科宝制药有限公司Chinese legal name: 北京四环科宝制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20052545
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20052545
Manufacturer
Chinese legal name: 北京四环科宝制药有限公司
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20052545
生产企业
北京四环科宝制药有限公司
适应症
用于脑卒中、脑供血不足所致脑功能减退和周围神经疾病的辅助治疗。
用法用量
1.肌内注射：加无菌注射用水溶解，一次3.5～7.0mg（以多肽计，1～2支），一日1～2次或遵医嘱；2.静脉滴注：一次7.0～17.5mg（以多肽计，2～5支），加无菌注射用水或输液溶解，溶解后加入500ml0.9%氯化钠注射液或5%～10%葡萄糖注射液中，缓慢滴注（滴注速度2ml/min），一日1次，两周为一疗程。
不良反应
个别患者出现发冷、发烧、体温略有升高，头晕、烦躁，调慢滴速，或停药后症状可消失。
禁忌
对本品中任何成份过敏者禁用。
注意事项
1、本品如出现西林瓶破裂或超过有效期，禁止使用。
贮藏
密闭，在常温(10～30℃)以下保存。
规格
多肽3.5mg与次黄嘌呤0.5mg。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.